Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/1993
07/14/1993EP0550478A1 Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions
07/14/1993EP0320507B1 Scaled-up production of liposome-encapsulated hemoglobin
07/13/1993US5227395 1-Phenoxycarbonyl-2-pyrrolidones
07/13/1993US5227294 Method of producing surfactin with the use of mutant of bacillus subtilis
07/13/1993CA1320205C 1,4-dihydro-4-(nitro)phenyl-3,5-pyridinecarboxylates incorporating an alkylaminoalkylene-heteroatom group moiety on one of the carboxylate groups
07/13/1993CA1320204C Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters
07/13/1993CA1320199C Substituted imidazolyl-alkyl-piperazine and-diazepine derivatives
07/08/1993WO1993013208A1 Methods for producing thrombin
07/08/1993WO1993013132A1 Novel megakaryocyte amplifier
07/08/1993WO1993012813A1 Methods and compositions for reducing blood loss
07/08/1993WO1993012810A1 Pharmaceutical pentapeptide compositions and methods of use thereof
07/08/1993WO1993012799A1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
07/08/1993CA2127275A1 Pharmaceutical pentapeptide compositions and methods of use thereof
07/07/1993EP0550383A1 Medicament containing crystalline fumaric acid salts of 9,9-alkylen-3,7diazabicyclononane compounds
07/07/1993EP0550008A2 Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells
07/07/1993EP0550006A2 Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
07/07/1993EP0549915A1 New synthetic isohirudines with enhanced stability
07/07/1993EP0549702A1 Uses of recombinant colony stimulating factor-1
07/07/1993EP0549660A1 Enhancement of glutathione levels with glutamine
07/07/1993EP0549598A1 2-METHYLIMIDAZO[4,5-c]PYRIDINE DERIVATIVES AND THERAPEUTIC AGENTS
07/07/1993CN1073978A Novel synthetic isohirudins with improved stability
07/06/1993US5225540 Hybridomas and Fab fragments
07/01/1993CA2086442A1 N-acyl derivatives of aminoalcohols active as local autocoidis and useful in the therapy of autoimmune processes
07/01/1993CA2086441A1 N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having meuroimmunogenic origin
06/1993
06/30/1993EP0549407A1 Novel pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them
06/30/1993EP0548949A2 Fused benzeneoxyacetic acid derivatives
06/30/1993EP0548825A1 Bradykinin-antagonists for the treatment of acute pancreatitis
06/30/1993EP0548227A1 Compounds
06/30/1993EP0548168A1 Imidazole derivatives, their preparation and pharmaceutical compositions
06/30/1993CN1073603A Anetic kinin antagon for curing acute pancreatitis
06/29/1993WO1993008282A1 New thrombin-inhibiting protein isolated from ticks
06/29/1993US5223517 Heterocyclically substituted cycloalkano[b]-indolesulphonamides
06/29/1993US5223427 Synthetic polypeptide
06/29/1993US5223422 T-pa mutant gk1l
06/29/1993US5223256 Thrombolytically active non-glycosylated protein
06/29/1993CA2121134A1 Novel thrombin-inhibitory protein from ticks
06/29/1993CA1319694C 4-oxo-7-substituted hydroxy-4h-benzopyrane derivatives
06/29/1993CA1319692C 2-methoxycarbonyl substituted n, n' -di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them
06/29/1993CA1319612C Iron-calcium mineral supplements with enhanced bioavailability
06/29/1993CA1319607C Antithrombotic pharmaceutical preparation and process for preparing same
06/28/1993CA2085844A1 Fused benzeneoxyacetic acid derivatives
06/24/1993WO1993012238A1 t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY
06/24/1993WO1993012225A1 Novel tissue plasminogen activator variants
06/24/1993WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/24/1993WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
06/24/1993WO1993010091A3 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
06/24/1993DE4241128A1 Transdermal aspirin dosage forms - for antithrombotic therapy or cancer prophylaxis
06/23/1993EP0547932A1 Process for preparing an activated factor VII concentrate having a high purity
06/23/1993EP0547705A1 Pharmacologically active tricyclic benzotriazepine derivatives
06/23/1993EP0547517A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation
06/23/1993EP0547180A1 Recombinant agents affecting thrombosis
06/23/1993EP0236330B1 Dna sequence encoding a hirudin-like protein and process for preparing such protein
06/23/1993CN1073433A Cyclohexaneacetic acid derivatives
06/23/1993CN1073357A Tocotrienols and tocotrienol-like compounds and methods for their use
06/19/1993CA2085705A1 Pharmacologically active tricyclic derivatives
06/17/1993DE4141377A1 New pyridyl derivs. used as thromboxane inhibitors - used to treat arteriosclerosis, ischaemia, asthma, allergy systemic lupus, shock etc.
06/16/1993EP0546813A2 Proteins for inhibiting adhesion of platelets to collagen
06/16/1993EP0546156A1 Isolation and characterization of a novel protease from streptomyces lividans
06/16/1993EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
06/16/1993CN1073169A 乙酸衍生物 Acetic acid derivatives
06/16/1993CN1021223C Process for 5-lipoxygense inhibiting 4-(4-phenyl-1-pip-erazing 1) phenols
06/15/1993US5219993 Method of recovering purified epi protein from a solution especially a fermentation solution
06/15/1993US5219874 Thromboxane synthetase inhibitors
06/15/1993US5219854 Administering 3/2H/-pyridazinone compound
06/15/1993US5219328 Fibrin sealant delivery method
06/15/1993CA1319151C2 ¬¬(3-pyridinyl)methylene|amino|alcohols
06/15/1993CA1319099C Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
06/11/1993CA2084834A1 Proteins for inhibiting adhesion of platelets to collagen
06/10/1993WO1993011280A1 Multiple solvent cleaning system
06/10/1993WO1993011239A1 New thrombin-inhibiting proteins from terrestrial leeches
06/10/1993WO1993011152A1 New peptide derivatives
06/10/1993WO1993011098A1 Fluorinated compounds as oxygen transport agents
06/10/1993WO1993010807A1 Hemoregulatory peptides
06/10/1993CA2124202A1 Hemoregulatory peptides
06/10/1993CA2123207A1 Multiple solvent cleaning system
06/10/1993CA2121601A1 Novel thrombin-inhibitory proteins from terrestrial leeches
06/09/1993EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates
06/09/1993EP0544681A1 A novel salicylic acid-maltol conjugates.
06/09/1993CN1072931A Crystalline fumarate of 9,9-alkylene-3.7-dinitrogen heterobis (cyclic nonane) compound and a drug containing said compound
06/09/1993CN1072843A Gel-type cosmetic composite
06/08/1993US5218108 Blood diluents and replacements
06/08/1993US5217992 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
06/08/1993US5217648 In physiologically compatible oil
06/02/1993EP0544592A2 High molecular weight N,O-sulfated heparosans, process for producing the same and pharmaceutical compositions containing them
06/02/1993EP0543858A1 Benzimidazole derivatives, process for their preparation and application
06/02/1993CN1072677A 芳族脒衍生物及其盐 Aromatic amidine derivatives and salts thereof
06/02/1993CN1072593A Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use
06/01/1993US5215895 Dna encoding a mammalian cytokine, interleukin-11
06/01/1993CA1318686C Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same
06/01/1993CA1318673C 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes
06/01/1993CA1318670C 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
06/01/1993CA1318619C Method of using eukaryotic expression vectors comprising the bk virus enhancer
05/1993
05/29/1993CA2083576A1 High molecular mass n,o-sulphated heparosans, process for their preparation and the pharmaceutical compositions which contain them
05/27/1993WO1993010114A1 3-pyridinol derivatives and their use as medicaments
05/27/1993WO1993010107A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase
05/27/1993WO1993010097A1 Nitro compounds having vasodilator activity
05/27/1993WO1993010093A1 2-pyridinol derivatives and their use as medicaments
05/27/1993WO1993010091A2 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
05/27/1993WO1993009869A1 Adsorbent for blood coagulation factor viii
05/27/1993WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES